Searched for
APOLLO HOSPITAL SHARE TARGET PRICE
PB Fintech shares crash 50% from peak, fall below 2021 IPO price. More downside coming?PB Fintech shares plunged 50% from their all-time high to drop below the 2021 IPO price of Rs 980. The sharp six-day selloff follows propos...- Moneyview shares skyrocket 82% from IPO price after strong market debut. Should you buy, sell or hold?Moneyview shares extended their strong debut gains on Thursday, rising as much as 82% from the IPO price. After listing at Rs 55.61 on the ...
- TBO Tek shares gain 3%; Nuvama initiates 'Buy' with Rs 2,200 targetShares of travel tech firm TBO Tek rose nearly 3% on Thursday to Rs 1,733 after brokerage Nuvama initiated coverage with a Buy rating and a...
- Fortis, Apollo, other hospital stocks slump up to 10% in 2 days after SC questions steep markups. Buying opportunity?Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...
- Cupid shares hit fresh 52-week high as firm raises FY27 revenue, profit guidance again; multibagger stock skyrockets 617% in a yearCupid shares hit a 52-week high after raising its FY27 guidance for the second time in two weeks, targeting Rs 800 crore revenue and Rs 250...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
- Hospital stocks slip after SC query on steep cancer drug markupsIn a landmark ruling, the Supreme Court of India highlighted troubling markups on cancer drugs enforced by hospitals, urging a probe into r...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities declined for a third straight session, with Sensex losing 49 points and Nifty falling 96 points as rising bond yields weigh...
- Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-upsHospital stocks came under pressure after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospita...
- Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerag...
- Bernstein cuts PB Fintech share price target by 53%. More pressure after Rs 37,000 m-cap rout?PB Fintech shares have plunged 42% in four sessions, wiping out Rs 37,000 crore in market value, following IRDAI’s proposed reforms to curb...
- Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s whyLenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA mar...
- FIIs dump telecom for 8th straight month, outflows cross Rs 32,000 crore. Are stocks set for rebound?Foreign portfolio investors have dumped Indian telecom stocks for the eighth consecutive month, pulling out over Rs 32,000 crore in CY26. H...
- Motilal Oswal sees Aster DM EBITDA rising 25% CAGR through FY28; sets Rs 910 targetMotilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expans...
- Goldman Sachs sees Eternal achieving $1 billion EBITDA by FY29; raises target priceGoldman Sachs maintained a Buy rating on Eternal, formerly Zomato, raising its target price by 11% to Rs 385. The brokerage foresees Eterna...
- Two Trades for Today: A defence electronics firm for a 7.05% rise, a large-cap power transmission maker for a gain of about 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- NSE shares fall 2%, slip below IPO price, but analysts’ target prices go up to Rs 2,050. Time to buy?NSE slipped below their Rs 1,785 IPO price on Monday, taking its market capitalisation to Rs 4.36 lakh crore. Despite the decline, brokerag...
- Meesho shares can fall 28%, warns Nomura after initiating coverage with Reduce call. Here is whyShares of Meesho dropped up to 5% to Rs 221 after Nomura initiated coverage with a Reduce rating and a Rs 167 target price, citing a 28% do...
- NSE draws brokerage attention on stock market debut as 3 firms initiate coverage on Day 1NSE shares rallied after a muted listing at Rs 1,800, pushing the exchange into India’s ninth-most valued company with a market cap of Rs 4...
- NMDC shares rally 2% after company sets target to achieve net-zero operational emissions by 2047NMDC shares rallied up to 2% on Monday to Rs 80.85 after setting a target to achieve net-zero operational emissions by 2047. Covering Scope...
Load More
